Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial)

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial)

Authors of this article:

Cari Stek^{1, 2, 3} ;   Charlotte Schutz^{1, 3} ;   Lisette Blumenthal^{1, 3} ;   Friedrich Thienemann^{1, 3} ;   Jozefien Buyze² ;   Christiana Nöstlinger⁴ ;   Raffaella Ravinetto² ;   Edwin Wouters⁵ ;   Robert Colebunders² ;   Gary Maartens³ ;   Robert J Wilkinson^{1, 3, 6, 7} ;   Lutgarde Lynen² ;   Graeme Meintjes^{1, 3}